Peptomyc CEO Laura Soucek was interviewed by Javier García Mateo, anchorman of ‘Primera Hora’ from Gestiona Radio. The show focuses on SMEs (PYMEsin Spanish), with small businesses and entrepreneurs from all sectors.

Laura talks about cancer treatment in general and some of the ongoing problems such as the enormous side effects of many current therapies. She highlights the significant advantages of Peptomyc’s approach to target Myc, and discusses the dramatic therapeutic effects observed in multiple mouse models of cancer – importantly without side effects. Laura also mentions the development of Peptomyc’s 1stproduct and the clinical trials that are due to start at the beginning of 2020.

Laura is featured in the program of the 28th of March 2018 at 10 am. The interview (in Spanish) begins at 45’30”.